Lifecore Biomedical, Inc. LFCR Payment-in-kind interest
Payment-in-kind interest at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaidInKindInterest.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s payment-in-kind interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s payment-in-kind interest?
- Lifecore Biomedical, Inc. (LFCR) reported payment-in-kind interest of $7.08M in Q1 2026.
- What does payment-in-kind interest mean?
- Represents interest expense that is settled through the issuance of additional debt or equity instruments rather than cash payments. This non-cash charge reflects the accrual of interest obligations that increase the total principal balance over time. Monitoring this metric is essential for assessing the impact of non-cash financing costs on the company's overall debt structure and future cash flow requirements.